Arcus Biosciences (RCUS) Long-Term Investments (2017 - 2025)
Historic Long-Term Investments for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $10.0 million.
- Arcus Biosciences' Long-Term Investments rose 40000.0% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 40000.0%. This contributed to the annual value of $14.0 million for FY2024, which is 8691.59% down from last year.
- Arcus Biosciences' Long-Term Investments amounted to $10.0 million in Q3 2025, which was up 40000.0% from $16.0 million recorded in Q2 2025.
- Arcus Biosciences' 5-year Long-Term Investments high stood at $218.7 million for Q3 2021, and its period low was $2.0 million during Q3 2024.
- In the last 5 years, Arcus Biosciences' Long-Term Investments had a median value of $90.0 million in 2023 and averaged $87.4 million.
- In the last 5 years, Arcus Biosciences' Long-Term Investments soared by 800111.11% in 2021 and then plummeted by 9867.55% in 2024.
- Over the past 5 years, Arcus Biosciences' Long-Term Investments (Quarter) stood at $182.0 million in 2021, then decreased by 29.12% to $129.0 million in 2022, then decreased by 17.05% to $107.0 million in 2023, then plummeted by 86.92% to $14.0 million in 2024, then fell by 28.57% to $10.0 million in 2025.
- Its Long-Term Investments was $10.0 million in Q3 2025, compared to $16.0 million in Q2 2025 and $8.0 million in Q1 2025.